US$ 28.10
tirzepatide gip agonist Effects of tirzepatide, a dual and GLP-1 receptor agonist, on blood pressure, cardiac function, and sympathetic nervous system in stroke-prone spontaneously hypertensive rats Main physiological actions of the
Description
Semaglutide is known to reduce body weight, largely via appetite suppression, in patients with obesity 5,6 and in adult mouse models 30,31

Importantly, this report was authored by health practitioners affiliated with a clinic selling BPC-157 injections, so theres a clear conflict of interest

This suggests that the incretin system, which retatrutide mimics and amplifies, is naturally more active at certain times of day

Some patients notice that injecting earlier in the day, rather than right before bed, reduces nighttime nausea and GI discomfort, which indirectly improves sleep

Tirzepatide has been shown to lower HbA1c (a marker of long-term blood sugar control) more effectively than many other diabetes medications, and it also leads to significant weight loss
